Nine-year follow up after hematopoietic stem cell transplantation in five multiple sclerosis patients
Arq. neuropsiquiatr; 77 (8), 2019
ABSTRACT Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system. Its treatment has focused on inflammation control as early as possible to avoid disability. Autologous hematopoietic stem cell transplantation (AHSCT) has been used for treating MS since 1996, with recent decisi...